LIF and pancreatic neoplasm: Furthermore, IL-6 showed a stronger ability to activate/phosphorylate STAT3 at Tyr705 than did LIF or another IL-6 family member, IL-11, in human pancreatic cancer cells (Supplementary Fig. 5a).